229 In another randomized, double-blind, placebo-controlled trial of 300 people with high cholesterol levels and at high risk of cardiovascular disease, subjects were randomized to receive either 180 mg of bempedoic acid, 10 mg of ezetimibe (which prevents the intestinal absorption of cholesterol), a combination of the two medications (180 mg of bempedoic acid and 10 mg of ezetimibe), or placebo in addition to stable statin therapy for 12 weeks
Failed clearance of aneuploid embryonic neural progenitor cells leads to excess aneuploidy in the Atm-deficient but not the Trp53-deficient adult cerebral cortex
[15] This comparison illustrates the scale of evidence difference between an FDA-approved agent with large-scale outcomes data and a compounded peptide with only preclinical cardiovascular data
It is accompanied by symptoms that can affect other areas of the body
PMID: 26786361 Szymko-Bennett YM, Mastroianni MA, Shotland LI, Davis J, Ondrey FG, Balog JZ, Rudy SF, McCullagh L, Levy HP, Liberfarb RM, Francomano CA, Griffith AJ